Nonischemic cardiomyopathy (NICM) represents a heterogeneous group of conditions that can cause left ventricular dysfunction. 1. Studies have suggested that patients with NICM who have received implantable cardioverter-defibrillator (ICD) therapy in addition to standard medical therapy have better survival.